ABCG2 and colonic neoplasm: Our results demonstrated that the levels of drug transporter proteins such as MDR1, MRP1, and ABCG2 were up-regulated in colon cancer cells treated with DOX and fidarestat treatment prevented the DOX-induced increase in the MDR1, MRP1, and ABCG2.